Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Mo | Median Technologies: eyonis Lung Cancer Screening (LCS) Meets Primary Endpoint in RELIVE Clinical Trial, the Final Pivotal Study Required for Regulatory Submissions | 194 | Business Wire | Primary endpoint met with statistical significance (p=0.027) in pivotal RELIVE trial of eyonis LCS, Median's AI/ML-based Software as a Medical Device for lung cancer screening
eyonis LCS... ► Artikel lesen | |
MEDIAN TECHNOLOGIES Aktie jetzt für 0€ handeln | |||||
Fr | Median Technologies Reports 2024 Key Financial Indicators and 2025 Outlook | 223 | Business Wire | H2 2024 revenue €12.0 million up 10.2% compared to H2 2023
FY 2024 revenue €22.9 million up 3.3% compared to 2023
Growing order backlog at €71.0 million, as of December 31, 2024... ► Artikel lesen | |
24.01. | Median Technologies securing up to €47.5 million to support AI lung cancer diagnostic eyonis regulatory filings and commercialization in U.S. and EU | 312 | Business Wire | Repayment of 2020 EIB loan to be rescheduled to October 2025 from April
New €37.5 million 2025 EIB loan under appraisal, final authorization stage
New up to €10 million equity line... ► Artikel lesen | |
14.01. | Median Technologies: Financial Communications Schedule for the First Half of 2025 | 308 | Business Wire | Regulatory News:
Median Technologies (FR0011049824, ALMDT, PEA-PME scheme eligible), announces the publication date for its 2024 results:
Publication
Date
... ► Artikel lesen | |
09.01. | Half Year Median Technologies Liquidity Contract Statement | 209 | Business Wire | Regulatory News:
Under the liquidity contract entrusted by Median Technologies (FR0011049824, ALMDT, PEA/SME eligible, "Median" or "the Company") to TP ICAP (Europe), the following resources were... ► Artikel lesen | |
08.01. | Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of December 31st, 2024 | 184 | Business Wire | Pursuant to article L-223-8 II of the French "code de Commerce" and 223-16 of the AMF's General Regulations.
Regulatory News:
Median Technologies (Paris:ALMDT):
Total number of shares... ► Artikel lesen | |
11.12.24 | Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of November 30th, 2024 | 234 | Business Wire | Pursuant to article L-223-8 II of the French "code de Commerce" and 223-16 of the AMF's General Regulations.
Regulatory News:
Median Technologies (Paris:ALMDT):
Total number of shares... ► Artikel lesen | |
26.11.24 | Median Technologies to Showcase AI-Powered Lung Cancer Diagnostic eyonis LCS at the Radiological Society of North America (RSNA) 2024 | 62 | Business Wire | Peer-reviewed scientific e-poster: "Performances of an End-to-End AI/ML CADe/CADx SaMD for Nodule Detection and Characterization in Lung Cancer Screening on an Independent Cohort Compared to Radiologists."... ► Artikel lesen | |
12.11.24 | Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of October 31st, 2024 | 279 | Business Wire | Pursuant to article L-223-8 II of the French "code de Commerce" and 223-16 of the AMF's General Regulations.
Regulatory News:
Median Technologies (Paris:ALMDT):
Total number of shares... ► Artikel lesen | |
07.11.24 | Median Technologies Hosted Insightful Key Opinion Leader (KOL) Webinar on eyonis Lung Cancer Screening (LCS) REALITY Data | 358 | Business Wire | Two globally leading pulmonologists reviewed REALITY data, AI and the potential impact on lung cancer screening
Replay in English is available on the link here
A French subtitled... ► Artikel lesen | |
30.10.24 | Median Technologies to Host Key Opinion Leader (KOL) Webinar on AI and Lung Cancer Screening | 293 | Business Wire | Webinar to focus on the eyonis Lung Cancer Screening (LCS) REALITY data
November 7, 2024 1:30 pm CET 7:30 am ET Registration link
Regulatory News:
Median Technologies (FR0011049824, ALMDT... ► Artikel lesen | |
24.10.24 | Median Technologies Reports 2024 Q3 Operational and Financial Update and 2024 Half-Year Results | 345 | Business Wire | eyonis LCS pivotal REALITY study met all primary and secondary endpoints
A webcast including Key Opinion Leaders will be held on November 7, 2024, to discuss the REALITY study results
... ► Artikel lesen | |
07.10.24 | Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of September 30th, 2024 | 286 | Business Wire | Pursuant to article L-223-8 II of the French "code de Commerce" and 223-16 of the AMF's General Regulations.
Regulatory News:
Median Technologies (Paris:ALMDT):
Total number of shares
... ► Artikel lesen | |
11.09.24 | Median Technologies to Attend and Present at the ESMO Congress 2024, Being Held in Barcelona, Spain, from Sept 13-17, 2024 | 479 | Business Wire | Peer-reviewed scientific poster for eyonis LCS
Median iCRO eyonis teams will be at booth #525, Exhibit Hall 3.
Regulatory News:
Median Technologies FR0011049824, ALMDT, PEA/SME eligible... ► Artikel lesen | |
06.09.24 | Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of August 31st, 2024 | 491 | Business Wire | Pursuant to article L-223-8 II of the French "code de Commerce" and 223-16 of the AMF's General Regulations.
Regulatory News:
Median Technologies (Paris:ALMDT):
Total number of shares... ► Artikel lesen | |
04.09.24 | Median Technologies to share positive pivotal data for eyonis LCS diagnostic software as medical device at the IASLC 2024 World Conference on Lung Cancer | 475 | Business Wire | (San Diego, CA, USA, from September 7-10, 2024)
eyonis LCS is a proprietary Software as Medical Device (SaMD) powered by artificial intelligence (AI) machine learning (ML) for early detection... ► Artikel lesen | |
02.09.24 | Median Technologies to host two webcasts on September 5, 2024 | 357 | Business Wire | eyonis LCS: New Horizons in Fighting Lung Cancer"
Regulatory News:
Median Technologies (FR0011049824, ALMDT, PEA/SME eligible, "Median" or "The Company") will host two live webcasts on September... ► Artikel lesen | |
29.08.24 | Median Technologies Announces Pivotal REALITY Study of Its eyonis LCS Lung Cancer Diagnostic Met All Primary and Secondary Endpoints | 285 | Business Wire | eyonis LCS met the primary endpoint for accuracy, achieving an Area Under the Curve (AUC)1 of 0.90, significantly above the 0.80 set for regulatory clearance.
eyonis LCS met all 9 secondary... ► Artikel lesen | |
08.08.24 | Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of July 31st, 2024 | 275 | Business Wire | Pursuant to article L-223-8 II of the French "code de Commerce" and 223-16 of the AMF's General Regulations.
Regulatory News:
Median Technologies (Paris:ALMDT):
Total number of shares... ► Artikel lesen | |
06.08.24 | Median Technologies Partners with a Top 10 Oncology Pharma Company to Apply AI for Imaging Biomarker Discovery | 370 | Business Wire | The partnership's aim is to identify predictive imaging biomarkers of patient response to a specific drug-candidate, using Imaging Lab's unique AI capabilities.
The company is a Top 10... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
PALANTIR TECHNOLOGIES | 96,39 | +18,20 % | Märkte am Morgen: Nvidia, AT&T, Apple, Palantir, Siemens Energy, SAP | Der deutsche Aktienmarkt hat einen spektakulären Auftakt in die neue Woche hingelegt. Der neue chinesische KI-Player DeepSeek sorgte für Verluste, die der DAX gestern schon zum Teil wettmachte. Heute... ► Artikel lesen | |
TEAMVIEWER | 11,670 | +1,39 % | 4.000-%-Aktie Carvana: TeamViewer, Bitcoin Group, Zalando, Credissential bieten Chancen | Abseits der großen Tech-Aktien lauern Vervielfacher. Ein Beispiel aus den USA ist die Carvana-Aktie mit 4.000 % innerhalb von 2 Jahren. Den Online-Gebrauchtwagenhändler herausfordern will Credissential.... ► Artikel lesen | |
ORACLE | 163,18 | -0,35 % | Börse am Morgen: Deepseek-Panik, Nvidia, Oracle, Siemens Energy, Ölpreis | Die Stimmung in den dt. Unternehmen hat sich zum Jahresauftakt etwas aufgehellt. Der ifo-Geschäftsklimaindex kletterte leicht auf 85,1 Punkte. Vor allem die aktuelle Lage zog an, immerhin auf den besten... ► Artikel lesen | |
SHOPIFY | 112,24 | +1,04 % | Shopify trotzt der Korrektur an den Börsen | Der kanadische Anbieter der bekannten E-Commerce-Plattform zeigte im gestrigen Handel an der Börse Stärke Den vollständigen Artikel lesen ... ► Artikel lesen | |
CROWDSTRIKE | 383,25 | -0,79 % | Märkte am Morgen: Siemens Energy, LVMH, Nvidia, Boeing, Xiaomi, Apple, ASML, Microsoft, Crowdstrike | Der DAX hat sich vom schwierigen Handel am Montag gut erholt gezeigt. Gestern begann er den Tag mit leichten Aufschlägen, legte dann im weiteren Verlauf aber immer mehr zu. Auch heute deuten sich nach... ► Artikel lesen | |
ZOOM COMMUNICATIONS | 82,78 | -1,08 % | Zoom Communications, Inc.: Zoom to Release Financial Results for the Fourth Quarter and Full Fiscal Year 2025 | SAN JOSE, Calif., Jan. 30, 2025 (GLOBE NEWSWIRE) -- Zoom Communications, Inc. (NASDAQ: ZM) today announced it will release its financial results for the fourth quarter and full fiscal year 2025 on Monday... ► Artikel lesen | |
ATOSS SOFTWARE | 119,60 | +0,17 % | EQS-News: ATOSS Software SE: Münchner Workforce Spezialist mit neuen Umsatz- und Ergebnisrekorden im Geschäftsjahr 2024 | EQS-News: ATOSS Software SE
/ Schlagwort(e): Jahresergebnis/Dividende
Münchner Workforce Spezialist mit neuen Umsatz- und Ergebnisrekorden im Geschäftsjahr 2024
31.01.2025... ► Artikel lesen | |
D-WAVE QUANTUM | 5,694 | +1,68 % | Neue KAUFWELLE! D-Wave, TUI, Saturn Oil + Gas - Aktien wollen Widerstände brechen | Die Quantum-Aktien sind verhältnismäßig gut durch das KI-Beben vom Montag gekommen. Dies zeigt, dass Investoren genau unterscheiden und nicht blind verkaufen. Ein gutes Timing hat D-Wave mit einer strategischen... ► Artikel lesen | |
RIOT PLATFORMS | 11,452 | -1,55 % | What the Options Market Tells Us About Riot Platforms | ||
FASTLY | 9,898 | +0,04 % | Fastly auf Wachstumskurs: Verluste schrumpfen | SAN FRANCISCO, Kalifornien (IT-Times) - Fastly hat seine Ergebnisse für das dritte Quartal des Geschäftsjahres 2024 bekannt gegeben und erneut ein zweistelliges Umsatzwachstum ausgewiesen. Fastly Aktie:... ► Artikel lesen | |
VEEVA SYSTEMS | 225,10 | -0,71 % | Veeva Systems: More Than 200 Companies Advance Trial Management with Veeva CTMS | Biopharmas use leading CTMS for improved trial efficiency and collaboration
BARCELONA, Spain, Jan. 29, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that more than... ► Artikel lesen | |
BRAINCHIP | 0,185 | +6,83 % | BrainChip Holdings Aktie: Ungeahnte Tücken! | Die BrainChip Holdings verzeichnete am Freitag einen deutlichen Kursrückgang an der Börse. Im Tradegate-Handel startete die Aktie zunächst bei 0,197 Euro, musste im Tagesverlauf jedoch spürbare Einbußen... ► Artikel lesen | |
VERSES AI | 0,906 | -3,10 % | Verses AI Inc: Verses AI adds global investment firm to Genius beta | ||
ATLASSIAN | 301,60 | -0,30 % | Cloud-Software: Atlassian profitiert von steigender Nachfrage | SYDNEY (IT-Times) - Der australische Kollaborations-Softwareanbieter Atlassian hat seine Ergebnisse für das zweite Quartal des Geschäftsjahres 2024/2025 veröffentlicht und erneut ein hohes Umsatzwachstum... ► Artikel lesen | |
HEXAGON | 11,140 | -0,58 % | Hexagon AB: Hexagon Year-End Report 1 January - 31 December 2024 | Fourth quarter 2024
• 1% organic revenue growth (using fixed exchange rates and a comparable group structure)
• Net sales increased by 1% to 1,448.0 MEUR (1,435.3)
• Adjusted gross margin of 66.7%... ► Artikel lesen |